PMID- 28790168 OWN - NLM STAT- MEDLINE DCOM- 20180608 LR - 20181113 IS - 1573-4935 (Electronic) IS - 0144-8463 (Print) IS - 0144-8463 (Linking) VI - 37 IP - 4 DP - 2017 Aug 31 TI - MicroRNA-211/BDNF axis regulates LPS-induced proliferation of normal human astrocyte through PI3K/AKT pathway. LID - BSR20170755 [pii] LID - 10.1042/BSR20170755 [doi] AB - Spinal cord injury (SCI) makes a major contribution to disability and deaths worldwide. Reactive astrogliosis, a typical feature after SCI, which undergoes varying molecular and morphological changes, is ubiquitous but poorly understood. Reactive astrogliosis contributes to glial scar formation that impedes axonal regeneration. Brain-derived neurotrophic factor (BDNF), a well-established neurotrophic factor, exerts neuroprotective and growth-promoting effects on a variety of neuronal populations after injury. In the present study, by using LPS-induced in vitro injury model of astroglial cultures, we observed a high expression of interleukin (IL)-6, IL-1beta, and BDNF in LPS-stimulated normal human astrocytes (NHAs). BDNF significantly promoted NHA proliferation. Further, online tools were employed to screen the candidate miRNAs which might directly target BDNF to inhibit its expression. Amongst the candidate miRNAs, miR-211 expression was down-regulated by LPS stimulation in a dose-dependent manner. Through direct targetting, miR-211 inhibited BDNF expression. Ectopic miR-211 expression significantly suppressed NHA proliferation, as well as LPS-induced activation of PI3K/Akt pathway. In contrast, inhibition of miR-211 expression significantly promoted NHA proliferation and LPS-induced activation of PI3K/Akt pathway. Taken together, miR-211/BDNF axis regulates LPS-induced NHA proliferation through PI3K/AKT pathway; miR-211/BDNF might serve as a promising target in the strategy against reactive astrocyte proliferation after SCI. CI - (c) 2017 The Author(s). FAU - Zhang, Kexiang AU - Zhang K AD - Department of Orthopedics, The Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Wu, Song AU - Wu S AD - Department of Orthopedics, The Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Li, Zhiyue AU - Li Z AD - Department of Orthopedics, The Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Zhou, Jiahui AU - Zhou J AD - Department of Orthopedics, The Third Xiangya Hospital, Central South University, Changsha 410013, China zjh5518@sina.com. LA - eng PT - Journal Article DEP - 20170821 PL - England TA - Biosci Rep JT - Bioscience reports JID - 8102797 RN - 0 (3' Untranslated Regions) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Lipopolysaccharides) RN - 0 (MIRN211 microRNA, human) RN - 0 (MicroRNAs) RN - 7171WSG8A2 (BDNF protein, human) RN - EC 2.7.1.137 (Phosphatidylinositol 3-Kinase) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - 3' Untranslated Regions MH - Astrocytes/*metabolism MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Cell Proliferation/*drug effects MH - Cells, Cultured MH - Cicatrix/metabolism MH - Dose-Response Relationship, Drug MH - Down-Regulation MH - HEK293 Cells MH - Humans MH - Lipopolysaccharides/*pharmacology MH - MicroRNAs/genetics/*metabolism MH - Phosphatidylinositol 3-Kinase/*metabolism MH - Proto-Oncogene Proteins c-akt/*metabolism MH - Spinal Cord Injuries/chemically induced PMC - PMC5563540 OTO - NOTNLM OT - Brain-derived Neurotrophic Factor (BDNF) OT - miR-211 OT - normal human astrocyte (NHA) OT - proliferation OT - spinal cord injury (SCI) COIS- The authors declare that there are no competing interests associated with the manuscript. EDAT- 2017/08/10 06:00 MHDA- 2018/06/09 06:00 PMCR- 2017/08/21 CRDT- 2017/08/10 06:00 PHST- 2017/05/05 00:00 [received] PHST- 2017/07/20 00:00 [revised] PHST- 2017/08/08 00:00 [accepted] PHST- 2017/08/10 06:00 [pubmed] PHST- 2018/06/09 06:00 [medline] PHST- 2017/08/10 06:00 [entrez] PHST- 2017/08/21 00:00 [pmc-release] AID - BSR20170755 [pii] AID - 10.1042/BSR20170755 [doi] PST - epublish SO - Biosci Rep. 2017 Aug 21;37(4):BSR20170755. doi: 10.1042/BSR20170755. Print 2017 Aug 31.